Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1956 1
1962 1
1975 1
1992 3
1993 1
1994 3
1996 2
1997 3
1998 3
1999 6
2000 6
2001 11
2002 8
2003 10
2004 10
2005 10
2006 10
2007 12
2008 15
2009 16
2010 24
2011 29
2012 17
2013 20
2014 19
2015 28
2016 23
2017 24
2018 23
2019 19
2020 34
2021 33
2022 36
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

424 results
Results by year
Filters applied: . Clear all
Page 1
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.
Spinner CD, Gottlieb RL, Criner GJ, Arribas López JR, Cattelan AM, Soriano Viladomiu A, Ogbuagu O, Malhotra P, Mullane KM, Castagna A, Chai LYA, Roestenberg M, Tsang OTY, Bernasconi E, Le Turnier P, Chang SC, SenGupta D, Hyland RH, Osinusi AO, Cao H, Blair C, Wang H, Gaggar A, Brainard DM, McPhail MJ, Bhagani S, Ahn MY, Sanyal AJ, Huhn G, Marty FM; GS-US-540-5774 Investigators. Spinner CD, et al. Among authors: bernasconi e. JAMA. 2020 Sep 15;324(11):1048-1057. doi: 10.1001/jama.2020.16349. JAMA. 2020. PMID: 32821939 Free PMC article. Clinical Trial.
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology.
Piccoli L, Park YJ, Tortorici MA, Czudnochowski N, Walls AC, Beltramello M, Silacci-Fregni C, Pinto D, Rosen LE, Bowen JE, Acton OJ, Jaconi S, Guarino B, Minola A, Zatta F, Sprugasci N, Bassi J, Peter A, De Marco A, Nix JC, Mele F, Jovic S, Rodriguez BF, Gupta SV, Jin F, Piumatti G, Lo Presti G, Pellanda AF, Biggiogero M, Tarkowski M, Pizzuto MS, Cameroni E, Havenar-Daughton C, Smithey M, Hong D, Lepori V, Albanese E, Ceschi A, Bernasconi E, Elzi L, Ferrari P, Garzoni C, Riva A, Snell G, Sallusto F, Fink K, Virgin HW, Lanzavecchia A, Corti D, Veesler D. Piccoli L, et al. Among authors: bernasconi e. Cell. 2020 Nov 12;183(4):1024-1042.e21. doi: 10.1016/j.cell.2020.09.037. Epub 2020 Sep 16. Cell. 2020. PMID: 32991844 Free PMC article.
Weight and Metabolic Changes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living With HIV : A Cohort Study.
Surial B, Mugglin C, Calmy A, Cavassini M, Günthard HF, Stöckle M, Bernasconi E, Schmid P, Tarr PE, Furrer H, Ledergerber B, Wandeler G, Rauch A; Swiss HIV Cohort Study. Surial B, et al. Among authors: bernasconi e. Ann Intern Med. 2021 Jun;174(6):758-767. doi: 10.7326/M20-4853. Epub 2021 Mar 16. Ann Intern Med. 2021. PMID: 33721521
[Antiretroviral therapy].
von Braun A, Furrer H, Battegay M, Calmy A, Cavassini M, Vernazza P, Bernasconi E, Weber R, Günthard HF. von Braun A, et al. Among authors: bernasconi e. Ther Umsch. 2014 Aug;71(8):461-8. doi: 10.1024/0040-5930/a000538. Ther Umsch. 2014. PMID: 25093310 Review. German.
[HIV-associated non-AIDS conditions].
Hasse B, Bernasconi E, Furrer H, Eyer MM, Kovari H. Hasse B, et al. Among authors: bernasconi e. Ther Umsch. 2014 Aug;71(8):483-9. doi: 10.1024/0040-5930/a000541. Ther Umsch. 2014. PMID: 25093313 Review. German.
Red herrings in monkeypox.
Bongiovanni M, Piccinini D, Aschwanden FJ, Bernasconi E. Bongiovanni M, et al. Among authors: bernasconi e. J Infect. 2022 Oct 20:S0163-4453(22)00619-3. doi: 10.1016/j.jinf.2022.10.024. Online ahead of print. J Infect. 2022. PMID: 36273643 Free PMC article. No abstract available.
Impact of Latent Tuberculosis on Diabetes.
Tepekule B, Kusejko K, Zeeb M, Tarr PE, Calmy A, Battegay M, Furrer H, Cavassini M, Bernasconi E, Notter J, Günthard HF, Nemeth J, Kouyos RD; Swiss HIV Cohort Study. Tepekule B, et al. Among authors: bernasconi e. J Infect Dis. 2022 Jun 15;225(12):2229-2234. doi: 10.1093/infdis/jiac054. J Infect Dis. 2022. PMID: 35172332
Enterococcus hirae infections in the clinical practice.
Piccinini D, Bernasconi E, Di Benedetto C, Martinetti Lucchini G, Bongiovanni M. Piccinini D, et al. Among authors: bernasconi e. Infect Dis (Lond). 2022 Sep 19:1-3. doi: 10.1080/23744235.2022.2125066. Online ahead of print. Infect Dis (Lond). 2022. PMID: 36121841 No abstract available.
Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL'HIV trial.
Sculier D, Wandeler G, Yerly S, Marinosci A, Stoeckle M, Bernasconi E, Braun DL, Vernazza P, Cavassini M, Buzzi M, Metzner KJ, Decosterd LA, Günthard HF, Schmid P, Limacher A, Egger M, Calmy A; Swiss HIV Cohort Study (SHCS). Sculier D, et al. Among authors: bernasconi e. PLoS Med. 2020 Nov 10;17(11):e1003421. doi: 10.1371/journal.pmed.1003421. eCollection 2020 Nov. PLoS Med. 2020. PMID: 33170863 Free PMC article. Clinical Trial.
424 results